Cargando…
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
Glioblastoma multiforme (GBM) is one of the most deadly types of cancer. To date, the best clinical approach for treatment is based on administration of temozolomide (TMZ) in combination with radiotherapy. Much evidence suggests that the intracellular level of the alkylating enzyme O(6)-methylguanin...
Autores principales: | Quintavalle, Cristina, Mangani, Davide, Roscigno, Giuseppina, Romano, Giulia, Diaz-Lagares, Angel, Iaboni, Margherita, Donnarumma, Elvira, Fiore, Danilo, De Marinis, Pasqualino, Soini, Ylermi, Esteller, Manel, Condorelli, Gerolama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798259/ https://www.ncbi.nlm.nih.gov/pubmed/24147153 http://dx.doi.org/10.1371/journal.pone.0074466 |
Ejemplares similares
-
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
por: Roscigno, Giuseppina, et al.
Publicado: (2015) -
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS
por: Fiore, Danilo, et al.
Publicado: (2016) -
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
por: Iaboni, Margherita, et al.
Publicado: (2016) -
Epigenetic Regulation of miR-212 Expression in Lung Cancer
por: Incoronato, Mariarosaria, et al.
Publicado: (2011) -
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer
por: Donnarumma, Elvira, et al.
Publicado: (2017)